Collegium Pharmaceutical, Inc. COLL Symproic and other — Finite-Lived Intangible Assets, Net
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsNet.
The official record: Collegium Pharmaceutical, Inc.’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Collegium Pharmaceutical, Inc.'s symproic and other — finite-lived intangible assets, net.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Collegium Pharmaceutical, Inc.'s symproic and other — finite-lived intangible assets, net?
- Collegium Pharmaceutical, Inc. (COLL) reported symproic and other — finite-lived intangible assets, net of $42.5M in Q4 2025.
- What does symproic and other — finite-lived intangible assets, net mean?
- The carrying value of intangible assets associated with the Symproic segment, calculated as the gross book value minus accumulated amortization. This represents the remaining unamortized economic value of the product rights or intellectual property on the balance sheet.